fasting and tirzepatide What to Expect After Starting Injections Media Centre | EASD

Visceral fat is tightly linked to metabolic dysfunction

A post-hoc analysis of pooled data from the SCALE Obesity and Prediabetes and SCALE Diabetes trial demonstrated notable differences in the proportion of early responders and early non-responders to liraglutide

In a phase 3 trial with 2,539 participants, tirzepatide (Eli Lilly) met both primary endpoints for mean percentage change in body weight from baseline and percentage of participants with a 5% reduction in body weight compared with placebo

The early data from obesity trials shows favorable trends in cardiovascular risk factors, but definitive outcome data remains forthcoming

Direct answer: When you stop semaglutide, its appetite and blood sugar effects wear off, so hunger increases and weight regain can happen over time

Dosage starts at 2.5 mg injected weekly